Goldman Sachs’s Rosetta Genomics ROSG Stock Holding History
Bought
Maintained
Sold
Other funds holding ROSG
HCM
Goldman Sachs's ROSG Position: Q1 2015 in Review
Goldman Sachs sold out of Rosetta Genomics (ROSG) in Q1 2015, closing a stake of 1,051 shares — an estimated $29K sold.
Goldman Sachs first reported a position in ROSG in Q3 2014 and held it in 2 quarters. The position peaked at $73K in Q3 2014. 12 funds tracked by Wall St. Rank hold ROSG as of Q1 2015.
- Goldman Sachs reported no remaining Rosetta Genomics position as of Q1 2015 after selling out during the quarter.
- Goldman Sachs sold 1,051 Rosetta Genomics shares in Q1 2015, an estimated $29K.
- Goldman Sachs first reported a position in Rosetta Genomics in Q3 2014 and held it in 2 quarters.
- Goldman Sachs's Rosetta Genomics position peaked at $73K in Q3 2014.
- 12 funds tracked by Wall St. Rank held Rosetta Genomics as of Q1 2015.
Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.